Andrew Reardon - 10 Jun 2025 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon
Issuer symbol
LGND
Transactions as of
10 Jun 2025
Net transactions value
-$57,271
Form type
4
Filing time
12 Jun 2025, 17:51:36 UTC
Previous filing
06 Mar 2025
Next filing
24 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reardon Andrew CLO & Secretary 555 HERITAGE DRIVE, SUITE 200, JUPITER /s/ Andrew Reardon 12 Jun 2025 0001950232

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Sale $57,271 -500 -1.5% $114.54 32,403 10 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.